about
Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptidePsychostimulants and brain dysfunction: a review of the relevant neurotoxic effects.Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia.Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunctionThe putative neuroprotective role of neuropeptide Y in the central nervous system.Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells.Long-Term Treatment with Low Doses of Methamphetamine Promotes Neuronal Differentiation and Strengthens Long-Term Potentiation of Glutamatergic Synapses onto Dentate Granule Neurons.Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier.Effects of drugs of abuse on the central neuropeptide Y system.Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity.Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown.Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.Protective role of neuropeptide Y Y₂ receptors in cell death and microglial response following methamphetamine injury.Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway.Ampakine CX546 increases proliferation and neuronal differentiation in subventricular zone stem/progenitor cell cultures.Testing the excitation/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes.Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.May exercise prevent addiction?Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin.Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels.Role of kainate receptor activation and desensitization on the [Ca(2+)](i) changes in cultured rat hippocampal neurons.Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus.Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures.Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex.Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain.Methylphenidate-triggered ROS generation promotes caveolae-mediated transcytosis via Rac1 signaling and c-Src-dependent caveolin-1 phosphorylation in human brain endothelial cells.Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9.Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures.Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia.Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory.Impact of developmental exposure to methylphenidate on rat brain's immune privilege and behavior: Control versus ADHD model.Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists.Impact of Neuroinflammation on Hippocampal Neurogenesis: Relevance to Aging and Alzheimer's Disease.Aquaporin-4 as a New Target against Methamphetamine-Induced Brain Alterations: Focus on the Neurogliovascular Unit and Motivational Behavior.Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures.Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment.Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus.Methamphetamine decreases dentate gyrus stem cell self-renewal and shifts the differentiation towards neuronal fate.Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures.
P50
Q28266011-F5B56969-19A0-4E3C-9169-DC02F0BB6EC4Q34398824-CEFDA393-DC64-4511-B407-A8B7428D7A23Q34439028-474691D9-A7D4-4905-B677-50482BCCCB16Q35564750-2AAB3E85-9008-4DFF-A09E-F841E2D71AA3Q35925469-ECCE350F-E205-42AB-8BF6-ECA134A041F1Q36230531-669B2B16-46DC-41E5-8937-77DE6F040ABDQ36536592-5C914A69-A279-4DEA-A779-5B03D8D83549Q37081184-83DD34F7-7881-4170-9536-36E71C11525EQ37826203-208C8229-4576-4AC3-ADBF-40AF04E9AA25Q38436912-31276363-7246-4769-9637-1E498007B287Q38933060-7CC4F201-C254-44DE-A981-9102F7F2388BQ38942008-2D666162-9EA3-40FB-A521-654ABA555081Q39013381-FA919E65-60C0-4855-BD6E-8934BAA182E5Q39313146-4CE3A9E0-3770-48A3-AD67-27978447FA67Q39340698-55FAAEA6-A226-44D0-8204-FCEA47E8D799Q39628717-7D061BF1-D4F6-4A1A-BD4B-F79F17146EDDQ41716345-32A5B16F-3115-4B1C-979C-2246B79AD30DQ42475710-8BE10127-1329-42AA-B933-00FCD617F44FQ42814769-25B6CB6C-53F3-40FC-8B32-5A05711DFCAEQ43194552-9BC7D333-7250-400A-BD6A-FC82184B5E75Q43588649-69C7EA98-9B79-489A-A881-68CC06A0D428Q43728411-E36EAA97-4CED-487F-8CA7-F8EF832B6568Q43777373-4CA299DF-6C24-479F-909E-9C6C983CD83FQ44530271-9D014B05-470C-4668-8211-20924A2F184DQ46258438-9FFD0A7E-3908-4516-8EA3-259A9973F35EQ46258489-C128F150-66ED-4BE7-84F4-7892AAA92D0CQ46523431-D9F9EF9B-9094-4A86-AB25-4213321FE7E0Q46592273-74FF259E-B060-42AD-947F-14490E2E05C5Q46610667-443D797E-A5EB-4E06-B92B-E9030C50B474Q46644687-2B103779-6083-4014-8637-8504E9EBC3E3Q46915616-089D6762-ACE2-43B7-885D-C1BD9E003433Q47591070-D6E38B76-A4DF-4AB5-A2A2-E893F07A4A28Q48122384-1B9BD40D-E98C-4D44-8892-5D6F5E0C4824Q48215184-3B3AB6FE-DB4B-4C8C-AAD3-3C78A3CDAD84Q48268644-7DF0D04D-3430-4A8F-8F5D-8DE5768CC1A1Q48315179-C1CECBCF-0565-49AD-8180-0D38A75DB8EBQ48338576-D5B4B590-1AAF-4B91-8D6B-A119B3D5E876Q48338937-DC01FEF5-97A2-44E8-AB68-B81DA4DC4D48Q48556749-2E4D57EB-3805-4763-BC7E-E5D51C5EEF88Q48633451-D27CD570-686F-4691-B3E5-355E764AA88A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana P. Silva
@ast
Ana P. Silva
@en
Ana P. Silva
@es
Ana P. Silva
@nl
Ana P. Silva
@sl
type
label
Ana P. Silva
@ast
Ana P. Silva
@en
Ana P. Silva
@es
Ana P. Silva
@nl
Ana P. Silva
@sl
altLabel
Silva AP
@en
prefLabel
Ana P. Silva
@ast
Ana P. Silva
@en
Ana P. Silva
@es
Ana P. Silva
@nl
Ana P. Silva
@sl
P1053
L-4184-2014
P106
P1153
7403222172
P21
P31
P3829
P496
0000-0002-7802-8690